You’re Eating Thousands of Microplastics a Year. Here’s What They’re Doing to Your Gut

Estimates suggest people swallow up to 52,000 microplastic particles per year through food, water, and packaging alone, and the number is likely far higher because detection methods still miss many of the smallest particles. A narrative review published in the journal Microorganisms by Michael Saadeh and colleagues synthesizes preclinical, in vitro, and limited human data to map what those particles may be doing inside the gastrointestinal tract. The findings are early and carry important caveats, but the biological mechanisms they describe are specific enough to warrant serious attention.

Microplastics in food reach the gut in surprising concentrations

Micro- and nanoplastics (MNPs) are defined as plastic particles smaller than 5 mm, with nanoplastics falling below 100 nm. They enter the food supply at nearly every stage: production, harvesting, processing, packaging, and storage. Drinking water, seafood, and processed foods are among the highest-burden sources. Infant feeding from polypropylene bottles is one striking example highlighted in the review: those bottles can release very high counts of microplastic particles per use, meaning exposure can begin before solid food is introduced.

Once ingested, most particles are excreted, but size determines how much biological mischief occurs along the way. Nanoplastics have significantly greater oral bioavailability and cellular internalization potential than their larger counterparts. They can cross epithelial barriers and distribute systemically to the liver, lung, kidney, and reproductive organs. Even particles that never leave the gut lumen can alter barrier and immune signaling. MNPs have been physically detected in colectomy specimens, confirming tissue-level exposure in the human colon is not hypothetical.

Gut microbiome diversity drops and pro-inflammatory bacteria rise

The most consistent signal in the reviewed literature is dysbiosis: a disruption of the gut microbial community that shifts the balance toward pro-inflammatory taxa. Animal and in vitro models show MNP exposure reduces overall microbial diversity, a change associated with gastrointestinal disorders and chronic systemic inflammation. Functional consequences follow: MNPs alter short-chain fatty acid (SCFA) production, the metabolic output of gut bacteria that normally reinforces the intestinal barrier and calibrates immune responses.

A further concern is genetic. Exposure to MNPs has been linked to shifts in the gut microbiota's functional metagenome, including an increase in antibiotic resistance genes. Bile acid metabolism is also disrupted. Bile acids regulate immune homeostasis in the gut, and a systematic review of microplastic impacts on microbial composition notes that this disruption may worsen colitis and lower the threshold for colorectal carcinogenesis. These are overlapping insults, and they compound one another.

Intestinal barrier damage and immune activation appear in preclinical models

Beyond the microbiome, MNPs appear to act directly on the gut lining. Animal studies show reduced mucus secretion and decreased expression of tight junction genes, the molecular staples that keep the intestinal epithelium sealed. The result is increased permeability, sometimes called "leaky gut," which allows microbial products and particles to cross into systemic circulation. Immune markers including TLR4 and IL-1 alpha are elevated, and T cell proportions shift in exposed animals.

Environmentally aged MNPs, particles that have weathered sun, heat, and microbial activity in the environment, show altered surface chemistry that makes them better at adsorbing toxic contaminants. This "Trojan horse" effect may amplify inflammation beyond what pristine lab particles produce, which matters because humans encounter aged plastics far more often than the fresh particles typically used in laboratory experiments.

Fecal microplastics are higher in IBD and colorectal cancer patients

Human biomonitoring data, while limited, add a provocative layer. Fecal microplastic concentrations are higher in patients with inflammatory bowel disease (IBD) compared to healthy controls, and they correlate with disease severity. Colorectal cancer (CRC) cases show higher fecal microplastic concentrations than controls, with a notable exposure-response relationship. Preclinical models extend this association: MNPs can act as tumor promoters in colitis-associated CRC models, increasing tumor burden. Polystyrene nanoplastics have been shown to alter gene expression in colorectal cancer cells in ways that promote cell migration, epithelial-to-mesenchymal transition, and cancer stem cell signatures.

The review also raises concerns about carcinogenic mechanisms operating at a molecular level. MNPs can induce oxidative stress, generating reactive oxygen species that damage DNA, proteins, and lipids. They can act as endocrine disruptors by adsorbing hormones and interfering with receptor signaling. They may also modulate epigenetic mechanisms in ways that favor cancer-promoting gene expression. These are plausible biological pathways, but the review is careful to note that the public health concern of microplastic intake has outrun definitive human evidence on any single outcome.

Key gaps make causal claims premature

The honest accounting in this review is one of its strengths. Most preclinical studies use acute, high-dose exposures with pristine particles, not the chronic low-dose exposures to environmentally aged mixtures that define real human experience. Nanoplastics are substantially undercharacterized in biomonitoring studies because current detection technology cannot reliably find them. Causal direction is genuinely unclear: does microplastic exposure worsen IBD, or do IBD patients consume diets that happen to carry higher microplastic burdens? Both directions are biologically plausible.

Harmonized reference materials and unified reporting metrics do not yet exist, which makes comparing results across studies unreliable. As a systematic review of microplastic research methods has noted, the absence of standardized biomarkers is a persistent barrier to drawing firm clinical conclusions. The Saadeh review frames its synthesis as a call for better-designed longitudinal human studies and improved analytical tools, not as a definitive verdict on risk.

What is clear is that the gastrointestinal tract is exposed to microplastics at levels that interact with the microbiome, the intestinal barrier, and the immune system in ways that look meaningful in controlled models. Whether those interactions translate to measurable disease burden in humans is the question that the next decade of research needs to answer.

Evidence rating

INVESTIGATIONAL — 71/100

Caveats:

• This is a narrative review, not an original study — it synthesizes existing evidence but cannot establish cause and effect on its own.
• Most mechanistic data come from animal and in vitro studies using high-dose, pristine plastic particles that do not reflect real-world human chronic exposure.
• Causality between MNP exposure and diseases like IBD or colorectal cancer has not been established — it is currently unknown whether MNPs cause disease or whether disease changes gut conditions that affect plastic retention.
• Standardized methods for measuring MNPs in human tissue are still lacking, making comparisons across studies unreliable.
• No funding source was disclosed for this review.

Narrative review synthesizing preclinical, in vitro, and limited human observational data on dietary microplastic and nanoplastic exposure and gastrointestinal health. The evidence base is dominated by animal and cell-culture models using exposure conditions that do not replicate chronic human dietary exposure, and human studies are largely cross-sectional or case-control in design, showing associations rather than causation. Causal relationships between MNP ingestion and GI disease remain unestablished, and the field lacks standardized biomonitoring methods needed for reliable cross-study comparison.

References

1. Michael Saadeh, Gordon Hong, Sana Rabeeah, Priyata Dutta, Edward C. Oldfield, David A. Johnson (2026). Dietary Intake of Micro- and Nanoplastics: Potential Adverse GI Effects on Microbiome, Inflammation, and Neoplasia. Microorganisms. https://doi.org/10.3390/microorganisms14061309
2. Sudipta Sankar Bora, Rahul Gogoi, Madhurjya Ranjan Sharma, et al. (2024). Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1492759
3. Zar Soe Thin, Jactty Chew, Timothy Yu Yee Ong, Raja Affendi Raja Ali, Lai Ti Gew (2025). Impact of microplastics on the human gut microbiome: a systematic review of microbial composition, diversity, and metabolic disruptions. BMC Gastroenterology. https://doi.org/10.1186/s12876-025-04140-2
4. Microscopic menace: exploring the link between microplastics and cancer pathogenesis. frontiersin.org. https://www.frontiersin.org/articles/10.3389/fpubh.2024.1378310/full
5. Avrina K Ririe, Nusrat Fatema, Tanni J Dina, et al. (2025). Impact of Microplastic Exposure on Human Health: A Systematic Review of Mechanisms, Biomarkers, and Clinical Outcomes. Cureus. https://doi.org/10.7759/cureus.100295